| For: | Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 [PMID: 30783370 DOI: 10.3748/wjg.v25.i6.659] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm |
| Number | Citing Articles |
| 1 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5) doi: 10.1080/17474124.2021.1900732
|
| 2 |
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen Melanoms. DMW - Deutsche Medizinische Wochenschrift 2022; 147(19) doi: 10.1055/a-1918-5473
|
| 3 |
Sohini Das, Manoj Job, Thomas Kodiatte, Ramya Iyadurai. Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady. Journal of Family Medicine and Primary Care 2019; 8(11) doi: 10.4103/jfmpc.jfmpc_748_19
|
| 4 |
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
|
| 5 |
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy
in patients with primary sclerosing cholangitis and IBD. Endoscopy International Open 2024; 12(11) doi: 10.1055/a-2437-8102
|
| 6 |
Caroline G Olson, Michael Picco, Francis A Farraye, Jana G Hashash, Jami Kinnucan. Clinical Characteristics of Patients With Ulcerative Colitis and Small Intestinal Malignancy. Crohn's & Colitis 360 2025; 7(3) doi: 10.1093/crocol/otaf041
|
| 7 |
Brian M. Fung, James H. Tabibian. Cholangiocarcinoma in patients with primary sclerosing cholangitis. Current Opinion in Gastroenterology 2020; 36(2) doi: 10.1097/MOG.0000000000000616
|
| 8 |
Kleoniki Kordeni, Antonios Vezakis, Theodoros Voulgaris, Athina Sotirianakou, Ekaterini Politi, Maria Gazouli. Methods improving endoscopic retrograde cholangiopancreatography brush cytology in malignant biliary strictures. World Journal of Gastroenterology 2026; 32(21): 117828 doi: 10.3748/wjg.v32.i21.117828
|
| 9 |
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, Mohammed Y Alghamdi, Abdullah S Alghamdi. Cholestatic liver disease. Saudi Journal of Gastroenterology 2021; 27(Suppl 1) doi: 10.4103/sjg.sjg_112_21
|
| 10 |
Mario Altieri, Olivier Sérée, Thierry Lobbedez, Philippe Segol, Armand Abergel, Xavier Blaizot, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Olivier Chazouillères, Maryline Debette-Gratien, Sébastien Dharancy, François Durand, Christophe Duvoux, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Pauline Houssel-Debry, Nassim Kamar, Marianne Latournerie, Pascal Lebray, Vincent Leroy, Martine Neau-Cransac, Georges-Philippe Pageaux, Sylvie Radenne, Ephrem Salamé, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Camille Besch, Guy Launoy, Jérôme Dumortier. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4) doi: 10.1016/j.clinre.2020.07.019
|
| 11 |
Nelli Sjöblom, Sonja Boyd, Hannu Kautiainen, Johanna Arola, Martti Färkkilä. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis. Histopathology 2022; 81(2) doi: 10.1111/his.14677
|
| 12 |
Dong He, Wen Zeng, Yi Wang, Yifan Xing, Kang Xiong, Nan Su, Chong Zhang, Yuan Lu, Xinhui Xing. Isolation and characterization of novel peptides from fermented products of Lactobacillus for ulcerative colitis prevention and treatment. Food Science and Human Wellness 2022; 11(6) doi: 10.1016/j.fshw.2022.06.003
|
| 13 |
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata, Yasuharu Imai. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis. Clinical Journal of Gastroenterology 2020; 13(6) doi: 10.1007/s12328-020-01204-6
|
| 14 |
Srija Manchkanti, Udhayvir Singh Grewal. Risk Factors and Outcomes of Patients With Cholangiocarcinoma and Primary Sclerosing Cholangitis. Mayo Clinic Proceedings 2025; 100(8) doi: 10.1016/j.mayocp.2025.04.013
|
| 15 |
Islam B. Mohamed, Ahmed El Sabagh, Fuad ZainAloor, Mohamed El Talkhan, Zahraa Al lami, Megha Bhongade, Shilpa Jain, Prasun K. Jalal. Hepatology. 2025; doi: 10.1016/B978-0-443-26711-6.00041-X
|
| 16 |
Saqr Alsakarneh, Razan Aburumman, Mohammad Bilal, Adam S. Faye, Jana G. Hashash, Aasma Shaukat. Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis. Alimentary Pharmacology & Therapeutics 2025; 62(11-12) doi: 10.1111/apt.70303
|
| 17 |
Lei Huang. 2020 International Conference on Applications and Techniques in Cyber Intelligence. Advances in Intelligent Systems and Computing 2021; 1244 doi: 10.1007/978-3-030-53980-1_27
|
| 18 |
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2022; doi: 10.1007/978-3-030-56993-8_80
|
| 19 |
Juan E. Corral, Kristopher P. Croome, Andrew P. Keaveny, Bhaumik Brahmbhatt, Paul T. Kröner, Karn Wijarnpreecha, Rohan M. Goswami, Massimo Raimondo, Michael B. Wallace, Yan Bi, Omar Y. Mousa. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant. Pancreas 2021; 50(1) doi: 10.1097/MPA.0000000000001722
|
| 20 |
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 2022; 18(03) doi: 10.1055/a-1364-8489
|
| 21 |
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021; 161(6) doi: 10.1053/j.gastro.2021.08.032
|
| 22 |
Katy L. Lawson, Hanlin L. Wang. Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic Cholangiopathy. Surgical Pathology Clinics 2023; 16(3) doi: 10.1016/j.path.2023.04.008
|
| 23 |
Stanisław Rządkowski, Agnieszka Chmielińska, Marek Pacholczyk, Beata Łągiewska. Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Transplantation Proceedings 2020; 52(8) doi: 10.1016/j.transproceed.2020.01.116
|
| 24 |
Agnes Wittek, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, Sandra Wende, Tanja Bedke, Jan Kempski, Marius Böttcher, Corinna Bang, Louise Thingholm, Till Krech, Ansgar W Lohse, Guido Sauter, Thomas Rösch, Andre Franke, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2024; 30(6) doi: 10.1093/ibd/izad137
|
| 25 |
Fiona Hand, Emir Hoti. Contemporary role of liver transplantation for the treatment of cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(6) doi: 10.1080/17474124.2020.1765771
|
| 26 |
Rhoda E. Kuc, Anna L. Paterson, Thomas L. Williams, William T. H. Gelson, Peter J. Greasley, Phil Ambery, Janet J. Maguire, Anthony P. Davenport. Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1680875
|
| 27 |
Martin Gregor, Julius Spicak, Michal Kahle, Petra Novotna, Mojmir Hlavaty, Pavel Drastich, Jan Brezina, Lukas Bajer, Ondrej Fabian, Petr Wohl, Alzbeta Krausova, Pavel Wohl. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
|
| 28 |
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Minerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
|
| 29 |
Fouad Jaber, George Cholankeril, Hashem B El-Serag. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. Journal of the Canadian Association of Gastroenterology 2024; 7(5) doi: 10.1093/jcag/gwae025
|
| 30 |
Mathew Vithayathil, Victoria Knott, Ian A Rowe, Shahid A Khan. Debate: pros and cons of surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis. Frontline Gastroenterology 2025; doi: 10.1136/flgastro-2025-103109
|
| 31 |
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. American Journal of Gastroenterology 2022; 117(1) doi: 10.14309/ajg.0000000000001525
|
| 32 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; doi: 10.1007/978-981-99-0815-8_55
|
| 33 |
Gabriel Mosquera-Klinger, Nathalie Yepes Madrid, Jhon Jaime Carvajal Gutiérrez. Enfermedad de Crohn con compromiso extenso y manifestaciones extradigestivas inusuales: a propósito de un caso . Revista colombiana de Gastroenterología 2021; 36(Supl. 1) doi: 10.22516/25007440.605
|
| 34 |
Marco Losa, Marlene Schwarzfischer, Marc Emmenegger, Marianne R. Spalinger, Gerhard Rogler, Michael Scharl. Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26168042
|
| 35 |
Gautham Appanna, Yiannis Kallis. An update on the management of cholestatic liver diseases. Clinical Medicine 2020; 20(5) doi: 10.7861/clinmed.2020-0697
|
| 36 |
Karoly Viragh, Maitraya Patel, Shaden Mohammad, Monica Deshmukh, Anokh Pahwa. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_7
|
| 37 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; doi: 10.1002/9781119756422.ch17
|
| 38 |
Michael Trauner, Chuhan Chung, Kate Sterling, Xiangyu Liu, Xiaomin Lu, Jun Xu, Clare Tempany-Afdhal, Zachary D. Goodman, Martti Färkkilä, Atsushi Tanaka, Palak Trivedi, Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Robert P. Myers. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02653-2
|
| 39 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. World Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
|
| 40 |
Nina Barner-Rasmussen, Antonio Molinaro, Bregje Mol, Cyriel Ponsioen, Annika Bergquist, Hannu Kautiainen, Martti A. Färkkilä. Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study. Endoscopy 2025; 57(05) doi: 10.1055/a-2511-3422
|
| 41 |
Hanlai Zhang, Yonghong Gao, Liqin Wang, Li Tian, Na An, Xinyu Yang, Xinye Li, Chao Tian, Mengchen Yuan, Xingjiang Xiong, Nian Liu, Hongcai Shang, Yanwei Xing. Does heart failure increase the risk of incident cancer? A meta-analysis and systematic review. Heart Failure Reviews 2020; 25(6) doi: 10.1007/s10741-019-09876-0
|
| 42 |
Richard Kellermayer, Marco Carbone, Thomas D. Horvath, Reka G. Szigeti, Cynthia Buness, Gideon M. Hirschfield, Peter J. Lewindon. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury. Hepatology 2025; 82(4) doi: 10.1097/HEP.0000000000000926
|
| 43 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6) doi: 10.14309/ajg.0000000000000604
|
| 44 |
Sara Momtazmanesh, Mehran Gholami, Neda Pak, Ali Reza Sima, Seyed Ali Montazeri, Shadi Kolahdoozan, Homayoun Vahedi, Amir Reza Radmard. The clinical significance of biliary findings in magnetic resonance enterography of patients with inflammatory bowel disease. Polish Journal of Radiology 2022; 87 doi: 10.5114/pjr.2022.121443
|
| 45 |
Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, Alyssa A. Grimshaw, Mashary Attamimi, Abdulelah AlMutairdi, Badr Al-Bawardy. Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848241312766
|
| 46 |
Anton Risto, Pär Myrelid, Jonas Söderling, Ola Olén, Caroline Nordenvall. Chance of pouch surgery after colectomy for ulcerative colitis based on pelvic pouch volumes at the colectomy hospital, a Swedish national cohort study. Colorectal Disease 2025; 27(9) doi: 10.1111/codi.70234
|
| 47 |
Taylor D. Ellington, Behnoosh Momin, Reda J. Wilson, S. Jane Henley, Manxia Wu, A. Blythe Ryerson. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(9) doi: 10.1158/1055-9965.EPI-21-0265
|
| 48 |
Florian Rennebaum, Claudia Demmig, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse, Jonel Trebicka, Wenyi Gu, Hansjoerg Ullerich, Iyad Kabar, Friederike Cordes. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study. International Journal of Molecular Sciences 2023; 24(20) doi: 10.3390/ijms242015431
|
| 49 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion. Zeitschrift für Gastroenterologie 2025; 63(03) doi: 10.1055/a-2460-6298
|
| 50 |
A.V. Nikitin, G.V. Volynets, T.A. Skvortsova, M.S. Kapranova. Extraintestinal manifestations of inflammatory bowel disease. Russian Journal of Evidence-Based Gastroenterology 2023; 12(1) doi: 10.17116/dokgastro20231201193
|
| 51 |
Ron Pery, Rory L Smoot, Cornelius A Thiels, Sean P Cleary, Robert A Vierkant, Sumera I Ilyas, Gregory J Gores, David M Nagorney. Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis. British Journal of Surgery 2022; 109(11) doi: 10.1093/bjs/znac229
|
| 52 |
Christopher Bowlus, Cynthia Levy, Kris V. Kowdley, Nandita Kachru, Sushanth Jeyakumar, Yael Rodriguez-Guadarrama, Nathaniel Smith, Andrew Briggs, Mark Sculpher, Daniel Ollendorf. Development of the natural history component of an early economic model for primary sclerosing cholangitis. Orphanet Journal of Rare Diseases 2025; 20(1) doi: 10.1186/s13023-025-03658-8
|
| 53 |
Florian Veyre, Claire Francoz, Domitille Erard, Eleonora DeMartin, Laure Elkrief, Camille Besch, Olivier Boillot, Filomena Conti, Sébastien Dharancy, Christophe Duvoux, Jean Gugenheim, Jean Hardwigsen, Marie‐Noëlle Hilleret, Vincent Leroy, Isabelle Ollivier‐Hourmand, Marilyne Gratien, Pauline Houssel‐Debry, Nassim Kamar, Olivier Roux, Jean‐Baptiste Hiriart, Marie Irles‐Depe, Sophie Pellegrin, François Durand, Georges‐Philippe Pageaux, Stéphanie Faure, Audrey Coilly, Sylvie Radenne, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Marianne Latournerie, Karim Boudjema, Ephrem Salamé, Olivier Chazouillères, Christophe Corpechot, Jérôme Dumortier. Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study. Liver International 2026; 46(4) doi: 10.1111/liv.70557
|
| 54 |
Zuzanna Lukasik, Dirk Elewaut, Koen Venken. MAIT Cells Come to the Rescue in Cancer Immunotherapy?. Cancers 2020; 12(2) doi: 10.3390/cancers12020413
|
| 55 |
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives. 2021; doi: 10.1016/B978-0-12-822028-3.00003-0
|
| 56 |
Sarah Poetter-Lang, Alina Messner, Nina Bastati, Kristina I. Ringe, Maxime Ronot, Sudhakar K. Venkatesh, Raphael Ambros, Antonia Kristic, Aida Korajac, Gregor Dovjak, Martin Zalaudek, Jacqueline. C. Hodge, Christoph Schramm, Emina Halilbasic, Michael Trauner, Ahmed Ba-Ssalamah. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. European Radiology 2023; 33(12) doi: 10.1007/s00330-023-09915-3
|
| 57 |
Anna Park, Andrew Vodinh‐Ho, Ivory Rok, Xinran Qi, George A. Hung, Nicholas Kikuta, Armaan Jamal, Gloria S. Kim, Latha P. Palaniappan, Malathi Srinivasan, Robert J. Huang, Adrian M. Bacong. Disaggregation of Hepatobiliary Cancer Mortality Among Asian Americans: Analysis of NVSS Mortality Data. Cancer Medicine 2025; 14(19) doi: 10.1002/cam4.71259
|
| 58 |
Teresa Brevini, Olivia C. Tysoe, Fotios Sampaziotis. Tissue engineering of the biliary tract and modelling of cholestatic disorders. Journal of Hepatology 2020; 73(4) doi: 10.1016/j.jhep.2020.05.049
|
| 59 |
Natassia Tan, Natalie Ngu, Thomas Worland, Tanya Lee, Tobie Abrahams, Elliot Freeman, Nicholas Hannah, Kathryn Gazelakis, Richie G Madden, Kate D Lynch, Zina Valaydon, Siddharth Sood, Anouk Dev, Sally Bell, Alexander J Thompson, John Nik Ding, Amanda J Nicoll, Ken Liu, Keval Pandya, Paul Gow, John Lubel, William Kemp, Stuart K Roberts, Ammar Majeed. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000442
|
| 60 |
Martina Taborelli, Michele Sozzi, Stefania Del Zotto, Federica Toffolutti, Marcella Montico, Loris Zanier, Diego Serraino, Jeffrey S. Chang. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy. PLOS ONE 2020; 15(6) doi: 10.1371/journal.pone.0235142
|
| 61 |
Lu Jiang, Peter Stärkel, Jian-Gao Fan, Derrick Eugene Fouts, Petra Bacher, Bernd Schnabl. The gut mycobiome: a novel player in chronic liver diseases. Journal of Gastroenterology 2021; 56(1) doi: 10.1007/s00535-020-01740-5
|
| 62 |
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Digestive and Liver Disease 2020; 52(11) doi: 10.1016/j.dld.2020.06.045
|
| 63 |
Sarah Kemme, Cara L. Mack. Pediatric Autoimmune Liver Diseases. Pediatric Clinics of North America 2021; 68(6) doi: 10.1016/j.pcl.2021.07.006
|
| 64 |
Ionut Eduard Iordache, Lucian-Flavius Herlo, Razvan Popescu, Daniel Ovidiu Costea, Luana Alexandrescu, Adrian Paul Suceveanu, Sorin Deacu, Gabriela Isabela Baltatescu, Alina Doina Nicoara, Nicoleta Leopa, Andreea Nelson Twakor, Andrei Octavian Iordache, Liliana Steriu. Cutting Edge: A Comprehensive Guide to Colorectal Cancer Surgery in Inflammatory Bowel Diseases. Journal of Mind and Medical Sciences 2025; 12(1) doi: 10.3390/jmms12010006
|
| 65 |
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports 2022; 4(11) doi: 10.1016/j.jhepr.2022.100553
|
| 66 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(01) doi: 10.1055/a-2189-6353
|
| 67 |
Dominic Staudenmann, Mark Bonnichsen, Payal Saxena, Arthur John Kaffes. Endoscopic Evaluation of Indeterminate Biliary Strictures: a Review. Current Treatment Options in Gastroenterology 2021; 19(2) doi: 10.1007/s11938-021-00339-w
|
| 68 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2025; 63(02) doi: 10.1055/a-2460-6347
|
| 69 |
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2) doi: 10.1080/17474124.2022.2031979
|
| 70 |
D. Bel Haj Yahia, M. Bel Hadj Yahya, I. Chelly, R. Ksantini, M. Jouini, M.J. Kacem. 21 years of evolution of primary hepatic neuroendocrine neoplasm in a patient with primary sclerosing cholangitis: A case report. International Journal of Surgery Case Reports 2023; 106 doi: 10.1016/j.ijscr.2023.108205
|
| 71 |
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_25
|
| 72 |
S. Franssen, D. M. de Jong, L. M. J. W. van Driel, B. Groot Koerkamp. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_9
|
| 73 |
Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World Journal of Gastrointestinal Oncology 2021; 13(10): 1336-1366 doi: 10.4251/wjgo.v13.i10.1336
|
| 74 |
Anita Nguyen, Babak Torabi Sagvand, Madeline Alizadeh, Cydney Nguyen, William Scott, Erik C. von Rosenvinge. Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans. Frontiers in Gastroenterology 2023; 1 doi: 10.3389/fgstr.2022.1076788
|
| 75 |
Marlone Cunha-Silva, Eloy Vianey Carvalho de França, Clauber Teles Veiga, Raquel Dias Greca, Priscilla Brito Sena de Moraes, Daniel Ferraz de Campos Mazo, Elaine Cristina de Ataíde, Simone Reges Perales, Leonardo Trevizan Monici, Tiago Sevá-Pereira. 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case report. Medicine 2022; 101(35) doi: 10.1097/MD.0000000000030315
|
| 76 |
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Archiv 2021; 479(6) doi: 10.1007/s00428-021-03183-6
|
| 77 |
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2020; doi: 10.1007/978-3-030-29964-4_80-1
|
| 78 |
Chaofu Li, Yating Deng, Yating Pan, Xinyi Liao, Huadong Xie, Xiaoli Xue, Shaoqing Yu, Wenlong Yu, Guanzhen Yu. Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning. Heliyon 2024; 10(18) doi: 10.1016/j.heliyon.2024.e37347
|
| 79 |
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E. Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall. Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control Study. Cancers 2023; 15(3) doi: 10.3390/cancers15030688
|
| 80 |
Haonan Zhang, Yulu Shi, Chanchan Lin, Chengcheng He, Shanping Wang, Qingyuan Li, Yan Sun, Mingsong Li. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1338918
|
| 81 |
Ahmad Hassan Ali, Elizabeth J. Carey. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_20
|
| 82 |
M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A. Kautz, G. Knötgen, J. Körber, D. Krug, F. Lammert, H. Lang, T. Langer, P. Lenz, A. Mahnken, A. Meining, O. Micke, S. Nadalin, H. P. Nguyen, J. Ockenga, K. Oldhafer, P. Paprottka, K. Paradies, P. Pereira, T. Persigehl, M. Plauth, R. Plentz, J. Pohl, J. Riemer, P. Reimer, J. Ringwald, U. Ritterbusch, E. Roeb, B. Schellhaas, P. Schirmacher, I. Schmid, A. Schuler, D. von Schweinitz, D. Seehofer, M. Sinn, A. Stein, A. Stengel, N. Steubesand, C. Stoll, A. Tannapfel, A. Taubert, J. Trojan, I. van Thiel, R. Tholen, A. Vogel, T. Vogl, H. Vorwerk, F. Wacker, O. Waidmann, H. Wedemeyer, H. Wege, D. Wildner, C. Wittekind, M. A. Wörns, P. Galle, N. Malek. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome. Zeitschrift für Gastroenterologie 2022; 60(02) doi: 10.1055/a-1589-7854
|
| 83 |
Patrick F. van Rheenen. Managing abnormal liver tests in children with inflammatory bowel disease. Current Opinion in Pediatrics 2021; 33(5) doi: 10.1097/MOP.0000000000001045
|
| 84 |
Amir Mohammad Salehi, Shayan Bahadivand Chegini, Sara Danaei, Maryam Hasanzarrini, Fatemeh Shahbazi. An Updated Meta-analysis of Pancreatic Cancer Risk in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01266-0
|
| 85 |
Peter Vien, Steven H. Sun, Laleh G. Melstrom. Gallbladder Cancer. 2024; doi: 10.1007/978-3-031-76746-3_3
|
| 86 |
Taranika Sarkar Das, Kimberly Ho, Jahnavi Udaikumar, Bryan Chen, Olivia Delau, Aasma Shaukat, Ira Jacobson, Raiya Sarwar. Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only. Hepatology Research 2024; 54(9) doi: 10.1111/hepr.14029
|
| 87 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|
| 88 |
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen Melanoms. TumorDiagnostik & Therapie 2024; 45(01) doi: 10.1055/a-2238-5283
|
| 89 |
Seul Kee Byeon, Saniha Sabu, Pamela S. Tietz-Bogert, Jagadheshwar Balan, Steven P. O’Hara, Nicholas F. LaRusso, Akhilesh Pandey. Lipidomic characterization of bile and serum reveals an altered lipid landscape in end-stage primary sclerosing cholangitis. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-45651-6
|
| 90 |
Xiaohui Wang, Ting Fu, Junqiao Wang, Changyuan Wang, Kexin Liu, Jingjing Wu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, Qiang Meng. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation. International Immunopharmacology 2019; 75 doi: 10.1016/j.intimp.2019.105833
|
| 91 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(02) doi: 10.1055/a-2189-8567
|
| 92 |
Amanda Ricciuto, Anne M Griffiths, Binita M Kamath, Eytan Wine, Rebecca Little. Gut microbiome in primary sclerosing cholangitis: A review. World Journal of Gastroenterology 2020; 26(21): 2768-2780 doi: 10.3748/wjg.v26.i21.2768
|
| 93 |
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.005
|
| 94 |
Silvia Cagnin, James H. Tabibian, Luca Fabris. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_10
|
| 95 |
Roongruedee Chaiteerakij. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_5
|
| 96 |
Vinay K. Kapoor. A Pictorial Treatise on Gall Bladder Cancer. 2021; doi: 10.1007/978-981-15-5289-2_4
|
| 97 |
Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto, Yusuke Yoshimatsu, Hiroki Kiyohara, Yukie Nakadai, Ryosuke Kasuga, Nobuhito Taniki, Keisuke Ojiro, Shingo Usui, Shogo Sunaga, Ichiro Mizushima, Yuta Kaieda, Shohei Suzuki, Takaya Tabuchi, Makoto Ueno. Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease. Journal of Gastroenterology 2026; doi: 10.1007/s00535-026-02388-3
|
| 98 |
Demis Pitoni, Arianna Dal Buono, Roberto Gabbiadini, Vincenzo Ronca, Francesca Colapietro, Nicola Pugliese, Davide Giuseppe Ribaldone, Cristina Bezzio, Ana Lleo, Alessandro Armuzzi. Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Cancers 2025; 17(13) doi: 10.3390/cancers17132165
|
| 99 |
Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo, Fernando Gomollón. Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers 2023; 15(3) doi: 10.3390/cancers15030871
|
| 100 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2023; 61(04) doi: 10.1055/a-2026-1240
|
| 101 |
Giacomo C. Waller, Umut Sarpel. Gallbladder Cancer. Surgical Clinics of North America 2024; 104(6) doi: 10.1016/j.suc.2024.03.006
|